Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Targeted Molecular Therapy

1 clinical trial

3 indications

Indication
Epidermal Growth Factor Receptor Activating Mutation
Indication
Recurrent Non-Small Cell Lung Carcinoma
Indication
Stage IV Non-Small Cell Lung Cancer
Clinical trial
Phase II Pilot Study Evaluating Strategies to Overcome Resistance at the Time of Progression for Patients With Non-small Cell Lung Cancers Harboring Major Oncogenic Drivers
Status: Terminated, Estimated PCD: 2018-01-08